List view / Grid view
8 June 2015 | By Select Biosciences
Select Biosciences is delighted to announce that its flagship congress now in its 7th year in San Diego, California, USA is being held September 28-30, 2015...
8 June 2015 | By Select Biosciences
Select Biosciences is delighted to announce that its Organ-on-a-Chip and 3D-Printing in the Life Sciences Conference, Boston, July 8-9, 2015 features all the international key opinion leaders in the organ-on-a-chip/body-on-a-chip field as well as 3D-bioprinting fields...
8 June 2015 | By Victoria White
A $10 billion market exists for a company able to develop a novel, targeted opioid therapy that excludes side effects such as addiction and constipation...
4 June 2015 | By Victoria White
When the T cells of your immune system are forced to deal over time with cancer or a chronic infection, they can develop "T cell exhaustion"...
4 June 2015 | By Victoria White
AmpliPhi's production facility in Ljubljana has been cleared by JAZMP to manufacture bacteriophages under current Good Manufacturing Practices standards...
4 June 2015 | By Victoria White
VBI Vaccines has delivered a presentation that supports the potential use of its eVLP platform in the development of a novel Hepatitis C vaccine candidate...
4 June 2015 | By Victoria White
The existing global collaboration between Celgene and bluebird bio has been amended and restated to focus on developing product candidates targeting BCMA...
4 June 2015 | By Victoria White
Lung cancer often returns and the recurring cancer is often resistant to the chemotherapy and other drugs that originally drove it into remission...
3 June 2015 | By Victoria White
Inovio has said it will advance its DNA vaccine for MERS into a Phase I clinical trial in healthy volunteers in a collaboration with GeneOne Life Science...
3 June 2015 | By Victoria White
MSD has extended its existing collaborative research agreement with Agenus for the discovery and development of therapeutic antibodies...
3 June 2015 | By Victoria White
Auspherix has raised £6 million in a Series A venture financing and is establishing operations on the Stevenage Bioscience Catalyst site...
3 June 2015 | By Victoria White
An investigational vaccine against Ebola, produced on ProBioGen’s proprietary, continuous muscovy duck AGE1.CR cell line, has proceeded into clinical trials...
3 June 2015 | By Victoria White
LDC and Qurient have signed a licence deal providing Qurient with exclusive worldwide rights to a series of highly-selective CDK7 inhibitors...
2 June 2015 | By Victoria White
Astellas Pharma and Anokion are to collaborate in the fields of type 1 diabetes and coeliac disease by establishing new drug discovery company Kanyos Bio...
2 June 2015 | By Victoria White
MGB Biopharma has developed a stable IV formulation of MGB-BP-3 for the treatment of Gram-positive hospital-acquired infections...
